Genetic modifications of pigs for medicine and agriculture

JJ Whyte, RS Prather - Molecular reproduction and …, 2011 - Wiley Online Library
Genetically modified swine hold great promise in the fields of agriculture and medicine.
Currently, these swine are being used to optimize production of quality meat, to improve our …

Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system

SA Brooks - Molecular biotechnology, 2004 - Springer
One of the commonest and least well understood posttranslational modifications of proteins
is their glycosylation. Human glycoproteins are glycosylated with a bewilderingly …

Genetic fusion to albumin improves the pharmacokinetic properties of factor IX

HJ Metzner, T Weimer, U Kronthaler… - Thrombosis and …, 2009 - thieme-connect.com
Haemophilia B is a X-chromosome linked disease characterised by a deficiency of
functionally active coagulation Factor IX (FIX). Patients with severe haemophilia B at risk of …

Comparison of chromatographic ion-exchange resins: IV. Strong and weak cation-exchange resins and heparin resins

A Staby, MB Sand, RG Hansen, JH Jacobsen… - … of Chromatography A, 2005 - Elsevier
A comparative study was performed on heparin resins and strong and weak cation
exchangers to investigate the pH dependence, efficiency, binding strength, particle size …

Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis)

PM Mannucci, M Vanoli, I Forza, MT Canciani… - …, 2003 - haematologica.org
BACKGROUND AND OBJECTIVES: Autoantibodies inactivating the von Willebrand factor
(VWF) cleaving protease, ADAMTS-13, are among the most frequent causes of thrombotic …

[HTML][HTML] The promise and challenges of bioengineered recombinant clotting factors

SW Pipe - Journal of Thrombosis and Haemostasis, 2005 - Elsevier
The past 10 years of clinical experience have demonstrated the safety and efficacy of
recombinant clotting factors. With the adoption of prophylactic strategies, there has been …

[HTML][HTML] DNA aptamer affinity ligands for highly selective purification of human plasma-related proteins from multiple sources

C Forier, E Boschetti, M Ouhammouch, A Cibiel… - … of Chromatography A, 2017 - Elsevier
Nucleic acid aptamers are promising ligands for analytical and preparative-scale affinity
chromatography applications. However, a full industrial exploitation requires that aptamer …

Genetically modified pigs for medicine and agriculture

RS Prather, M Shen, Y Dai - Biotechnology and Genetic …, 2008 - Taylor & Francis
The ability to genetically modify pigs has enabled scientists to create pigs that are beneficial
to humans in ways that were previously unimaginable. Improvements in the methods to …

High throughput quantification of N-glycans using one-pot sialic acid modification and matrix assisted laser desorption ionization time-of-flight mass spectrometry

GC Gil, B Iliff, R Cerny, WH Velander… - Analytical …, 2010 - ACS Publications
Appropriate glycosylation of recombinant therapeutic glycoproteins has been emphasized in
biopharmaceutical industries because the carbohydrate component can affect safety …

The hope and reality of long‐acting hemophilia products

SW Pipe - American journal of hematology, 2012 - Wiley Online Library
Recombinant DNA technology and protein engineering are creating hope that we can
address ongoing challenges in hemophilia care such as reducing the costs of therapy …